Médico Cirujano año de obtención 2000.
Especialidad Médica u Odontológica
Cirugía General año de obtención 2003, Cirugía Digestiva año de obtención 2011.
* Gonzalez-Hormazabal, P; Musleh, M; Bustamante, M; Stambuk, J; Pisano, R; Valladares, H; Lanzarini, E; Chiong, H; Rojas, J; Suazo, J; Castro, VG; Jara, L; Berger, Z “Polymorphisms in RAS/RAF/MEK/ERK Pathway Are Associated with Gastric Cancer” 2019. Genes. http://dx.doi.org/10.3390/genes10010020
* Figueroa-Giralt, M; Csendes, A; Carrillo, K; Danilla, S; Lanzarini, E; Braghetto, I; Musleh, M; Cortes, S “Introduction of the new lymphoparietal index for gastric cancer patients” 2019. ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY. http://dx.doi.org/10.1590/0102-672020190001e1441
* Braghetto, I; Lanzarini, E; Musleh, M; Korn, O; Lasnibat, JP “Thinking About Hiatal Hernia Recurrence After Laparoscopic Repair: When Should It Be Considered a True Recurrence? A Different Point of View” 2018. INTERNATIONAL SURGERY. http://dx.doi.org/10.9738/INTSURG-D-17-00123.1
* Norero, E; Funke, R; Garcia, C; Fernandez, JI; Lanzarini, E; Rodriguez, J; Ceroni, M; Crovari, F; Pinto, G; Musleh, M; Gonzalez, P. “National Trend in Laparoscopic Gastrectomy for Gastric Cancer: Analysis of the National Register in Chile” 2018. DIGESTIVE SURGERY. http://dx.doi.org/10.1159/000485197
* Gonzalez-Hormazabal, P; Musleh, M; Escandar, S; Valladares, H; Lanzarini, E; Castro, VG; Jara, L; Berger, Z. “Prevalence of clarithromycin resistance in Helicobacter pylori in Santiago, Chile, estimated by real-time PCR directly from gastric mucosa”. 2018. BMC GASTROENTEROLOGY. http://dx.doi.org/10.1186/s12876-018-0820-0
* Romero, S; Musleh, M; Bustamante, M; Stambuk, J; Pisano, R; Lanzarini, E; Chiong, H; Rojas, J; Castro, VG; Jara, L; Berger, Z; Gonzalez-Hormazabal, P. “Polymorphisms in TWIST1 and ZEB1 are associated with prognosis of gastric cancer patients”. 2018. ANTICANCER RESEARCH. http://dx.doi.org/10.21873/anticanres.12671
* Gonzalez-Hormazabal, P; Romero, S; Musleh, M; Bustamante, M; Stambuk, J; Pisano, R; Lanzarini, E; Chiong, H; Rojas, J; Castro, VG; Jara, L; Berger, Z. “IL-8-251T>A (rs4073) polymorphism is associated with prognosis in gastric cancer patients”. 2018. ANTICANCER RESEARCH. http://dx.doi.org/10.21873/anticanres.12907
- Proyecto Fondecyt Regular Nº1151015
Título “Involvement of Genetic variation of H. Pylori Cag Pathogenicity Island (cagpai) and of Host Polymorphism in caga-activated pathways in gastric Cancer Risk and Prognosis”
Participa como Co-Investigador
Desde marzo de 2015
Hasta marzo 2019
MK3475-585
A Phase III, Randomized,double blind, clinical trial of pembrolizumab (MK-3475) Plus Chemotherapy (XP OR FP) Versus Placebo Plus Chemotherapy (XP OR FP) as neoadjuvant/ adjuvant treatment for subjects with gastric and gastroesophageal junction adenocarcinoma.
Co-Investigador
Desde Diciembre 2018- 2023